ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Evox raises £69.2m to advance exosome-based therapeutics pipeline
February 19, 2021Oxford-based biotech company Evox Therapeutics has completed a Series C financing round, announcing that it has raised £69.2m ($95.4m) following ‘high demand’ from existing and new investors. -
Takeda, Evox link up to the tune of $882m
March 30, 2020Evox has announced a new rare disease collaboration with Takeda to develop up to five novel protein replacement and mRNA therapies. -
Evox bags grant from Duchenne UK to engineer exosomes
November 14, 2018Evox Therapeutics has secured £655,000 in funding from Duchenne UK, to support exploration of its exosome-based therapeutic platform for the condition. -
Evox raises £35m for exosome therapeutics
September 14, 2018Oxford, UK-based Evox Therapeutics has raised £35 million to help advance its exosome-based therapeutics pipeline.
Pharma Sources Insight January 2025
